Literature Collection

Collection Insights

10K+

References

9K+

Articles

1400+

Grey Literature

4500+

Opioids & SU

The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
10858 Results
3141
Drug consumption facility as part of a primary health care centre for problem drug users - which clients are attracted?
Type: Journal Article
Authors: N. Scherbaum, M. Specka, J. Bombeck, B. Marrziniak
Year: 2009
Publication Place: Netherlands
Abstract: BACKGROUND: To investigate whether users of a drug consumption facility (DCF) established as part of a health care centre for problem drug users fulfilled entry criteria, especially public drug consumption, risky drug-application and housing problems. We also investigated whether the drug consumption facility attracted hard-to-reach opiate users who usually do not use the health care system. METHODS: Structured interviews were carried out with 129 problem drug users beginning attendance at a drug consumption facility. RESULTS: Median length of the current episode of regular heroin use was 3 weeks. Sixty-seven per cent of clients had been in addiction specific treatment or had left prison during the previous 3 months. Regarding behaviour in the last month, 53% reported drug use in public, 53% use of non-sterile equipment or water, 22% needle sharing, 8% reported an emergency admission to hospital, and 43% were living in unstable accommodation. Only 10% of clients had never received treatment for their drug use and 87% were currently in contact with psychosocial services. CONCLUSIONS: The majority of clients were chronic opiate users with high rates of risk behaviour. However, they did have recent contact with the drug treatment system. DCFs may be particularly important for opiate users after prison or treatment and/or for those with unstable accommodation.
Topic(s):
Opioids & Substance Use See topic collection
3142
Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
Type: Journal Article
Authors: A. T. McLellan, D. C. Lewis, C. P. O'Brien, H. D. Kleber
Year: 2000
Publication Place: United States
Abstract: The effects of drug dependence on social systems has helped shape the generally held view that drug dependence is primarily a social problem, not a health problem. In turn, medical approaches to prevention and treatment are lacking. We examined evidence that drug (including alcohol) dependence is a chronic medical illness. A literature review compared the diagnoses, heritability, etiology (genetic and environmental factors), pathophysiology, and response to treatments (adherence and relapse) of drug dependence vs type 2 diabetes mellitus, hypertension, and asthma. Genetic heritability, personal choice, and environmental factors are comparably involved in the etiology and course of all of these disorders. Drug dependence produces significant and lasting changes in brain chemistry and function. Effective medications are available for treating nicotine, alcohol, and opiate dependence but not stimulant or marijuana dependence. Medication adherence and relapse rates are similar across these illnesses. Drug dependence generally has been treated as if it were an acute illness. Review results suggest that long-term care strategies of medication management and continued monitoring produce lasting benefits. Drug dependence should be insured, treated, and evaluated like other chronic illnesses. JAMA. 2000;284:1689-1695.
Topic(s):
Opioids & Substance Use See topic collection
3143
Drug Diversion Toolkit: Buprenorphine-- A Primer for Prescribers and Pharmacists
Type: Government Report
Authors: Centers for Medicare and Medicaid Services
Year: 2015
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3144
Drug Diversion Toolkit: Prescription Opioids-An Overview for Prescribers and Pharmacists
Type: Government Report
Authors: Centers for Medicare and Medicaid Services
Year: 2016
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3145
Drug list as a cognitive support to provide detailed information on a patient's drug use: A comparison of two methods within the assessment of drug misuse and dependence
Type: Journal Article
Authors: Bodil Monwell, Olof Blix, Arne Gerdner, Per Bulow
Year: 2016
Topic(s):
Opioids & Substance Use See topic collection
3146
Drug Overdose Deaths in the United States, 1999-2015
Type: Government Report
Authors: Holly Hedegaard, Margaret Warner, Arialdi M. Minino
Year: 2017
Publication Place: Hyattsville, MD
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3147
Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004-2019
Type: Journal Article
Authors: M. Kariisa, P. Seth, L. Scholl, N. Wilson, N. L. Davis
Year: 2021
Publication Place: Ireland
Abstract:

BACKGROUND: Drug overdose deaths involving stimulants, including cocaine and psychostimulants with abuse potential (e.g., methamphetamine), have been increasing, partly because of co-involvement with opioids. Stimulant-involved overdose deaths have disproportionately increased among non-Hispanic Black (Black) and non-Hispanic American Indian/Alaskan Native (AI/AN) persons; however, the role of opioids in exacerbating disproportionate stimulant-involved death rates is unclear. METHODS: Analysis of National Vital Statistics System multiple cause-of-death mortality files examined age-adjusted cocaine- and psychostimulant-involved death rates. Analyses of death rates stratified by racial and ethnic group and opioid co-involvement included: 1) Joinpoint regression of 2004-2019 trends, 2) changes in rates from 2018 to 2019, and 3) demographic and geographic characteristics of 2019 deaths. RESULTS: From 2004 to 2019, cocaine and psychostimulant-involved death rates were higher for Black and AI/AN persons, respectively. Among all groups, increases in cocaine-involved overdose rates were largely driven by opioid co-involvement, particularly after 2013. From 2004 to 2019, rates for psychostimulant-involved deaths increased with and without opioid co-involvement. Rates for overdoses co-involving cocaine and synthetic opioids increased from 2018 to 2019 for Hispanic, non-Hispanic White (White), and Black persons. Psychostimulant-involved overdose rates with and without synthetic opioid co-involvement increased among Hispanic, White, and Black persons. In 2019, Black and AI/AN persons continued to experience higher cocaine- and psychostimulant-involved death rates, respectively. CONCLUSIONS: Stimulant-involved deaths continue to increase, and the role of opioids in driving these deaths varies by race and ethnicity. Ensuring equitable access to proven prevention and treatment interventions and incorporating social determinants of health into future research around effective pharmacotherapies may help reduce stimulant-involved overdose deaths.

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
3148
Drug overdose immunity and good samaritan laws
Type: Web Resource
Authors: National Conference of State Legislatures
Year: 2017
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3149
Drug safety alert generation and overriding in a large Dutch university medical centre
Type: Journal Article
Authors: H. van der Sijs, A. Mulder, T. van Gelder, J. Aarts, M. Berg, A. Vulto
Year: 2009
Publication Place: England
Abstract: PURPOSE: To evaluate numbers and types of drug safety alerts generated and overridden in a large Dutch university medical centre. METHODS: A disguised observation study lasting 25 days on two internal medicine wards evaluating alert generation and handling of alerts. A retrospective analysis was also performed of all drug safety alerts overridden in the hospital using pharmacy log files over 24 months. RESULTS: In the disguised observation study 34% of the orders generated a drug safety alert of which 91% were overridden. The majority of alerts generated (56%) concerned drug-drug interactions (DDIs) and these were overridden more often (98%) than overdoses (89%) or duplicate orders (80%). All drug safety alerts concerning admission medicines were overridden.Retrospective analysis of pharmacy log files for all wards revealed one override per five prescriptions. Of all overrides, DDIs accounted for 59%, overdoses 24% and duplicate orders 17%. DDI alerts of medium-level seriousness were overridden more often (55%) than low-level (22%) or high-level DDIs (19%). In 36% of DDI overrides, it would have been possible to monitor effects by measuring serum levels. The top 20 of overridden DDIs accounted for 76% of all DDI overrides. CONCLUSIONS: Drug safety alerts were generated in one third of orders and were frequently overridden. Duplicate order alerts more often resulted in order cancellation (20%) than did alerts for overdose (11%) or DDIs (2%). DDIs were most frequently overridden. Only a small number of DDIs caused these overrides. Studies on improvement of alert handling should focus on these frequently-overridden DDIs.
Topic(s):
HIT & Telehealth See topic collection
3150
Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians
Type: Journal Article
Authors: M. Gahr, J. Eller, M. Cabanis, C. Hiemke, R. W. Freudenmann, B. J. Connemann, D. Lang, C. Schonfeldt-Lecuona
Year: 2017
Publication Place: United States
Topic(s):
Opioids & Substance Use See topic collection
3151
Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians
Type: Journal Article
Authors: M. Gahr, J. Eller, M. Cabanis, C. Hiemke, R. W. Freudenmann, B. J. Connemann, D. Lang, C. Schonfeldt-Lecuona
Year: 2017
Publication Place: United States
Topic(s):
Opioids & Substance Use See topic collection
3152
Drug treatment for prisoners: Opioid substitution treatment, therapeutic communities, and cognitive behavioral therapy
Type: Book Chapter
Authors: Kate Dolan, Zahra Alam-Mehrjerdi, Babak Moazen
Year: 2018
Publication Place: New York, NY
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3153
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
Type: Journal Article
Authors: David A. Fiellin, Linda Weiss, Michael Botsko, James E. Egan, Frederick L. Altice, Lauri B. Bazerman, Amina Chaudhry, Chinazo O. Cunningham, Marc N. Gourevitch, Paula J. Lum, Lynn E. Sullivan, Richard S. Schottenfeld, Patrick G. O'Connor
Year: 2011
Topic(s):
Opioids & Substance Use See topic collection
3154
Drug type and high risk behaviors associated with health-care utilization among people who inject drugs: A systematic review and meta-analysis
Type: Journal Article
Authors: Bahram Armoon, Azadeh Bayani, Rasool Mohammadi, Elaheh Ahounbar, Peter Higgs
Year: 2022
Topic(s):
Healthcare Disparities See topic collection
,
Financing & Sustainability See topic collection
3155
Drug type and high risk behaviors associated with health-care utilization among people who inject drugs: a systematic review and meta-analysis
Type: Journal Article
Authors: Bahram Armoon, Azadeh Bayani, Rasool Mohammadi, Elaheh Ahounbar, Peter Higgs
Year: 2024
Topic(s):
Opioids & Substance Use See topic collection
,
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
3156
Drug Use and Viral Infections (HIV, Hepatitis) DrugFacts
Type: Government Report
Authors: National Institute on Drug Abuse
Year: 2020
Publication Place: Bethesda, MD
Topic(s):
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3157
Drug Use Disorder (DUD) Questionnaire: Scale development and validation
Type: Journal Article
Authors: M. Scherer, C. D. Furr-Holden, R. B. Voas
Year: 2013
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
3158
Drug use in pregnancy in Ireland's capital city: A decade of trends and outcomes
Type: Journal Article
Authors: G. A. Corbett, D. Carmody, M. Rochford, O. Cunningham, S. W. Lindow, M. P. O'Connell
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
3159
Drugs and pregnancy-outcomes of women engaged with a specialist perinatal outreach addictions service
Type: Journal Article
Authors: Soraya Mayet, Teodora Groshkova, Louise Morgan, Tracey MacCormack, John Strang
Year: 2008
Topic(s):
Opioids & Substance Use See topic collection
3160
Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016
Type: Government Report
Authors: Holly Hedegaard, Brigham Bastian, James Trinidad, Merianne Spencer, Margaret Warner
Year: 2018
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.